Eduard Gallardo has been appointed group leader of the U762 CIBERER at the Hospital de Sant Pau in Barcelona to replace Isabel Illa. This research team is specialized in neuromuscular diseases.
Dr. Gallardo has been working since 1993 in the field of non-immune neuropathies, myasthenia, inflammatory myopathies and muscular dystrophies, and more specifically in dysferlinopathies. He has more than 100 publications (PubMed) in the field of neuromuscular diseases and has been principal investigator of 12 research projects.